The FDA's Call for Cash (The Motley Fool)
If more money would speed approvals, drug companies should be happy.

FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting (The San Francisco Examiner)
WOODCLIFF LAKE, N.J. ( Map ) - WOODCLIFF LAKE, N.J., March 2 /PRNewswire/ -- Eisai Corporation of North America , its U.S. subsidiary, MGI PHARMA, INC., and Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved Aloxi(R) (palonosetron hydrochloride) injection for the prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following ...